Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia.

Loading...
Thumbnail Image
Authors
Sheu, J-J
Lee, F-Y
Wallace, Christopher G
Tsai, T-H
Leu, S
Chen, Y-L
Chai, H-T
Lu, H-I
Sun, C-K
Yip, H-K
Journal
Journal of translational medicine
Type
Journal Article
Research Support, Non-U.S. Gov't
Publisher
BioMed Central
Rights
Archived with thanks to Journal of translational medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
We hypothesized that lung cancer patient's circulating microparticles (Lc-MPs) could promote angiogenesis, blood flow in ischemic zone and ischemic recovery in rat critical limb ischemia (CLI).
Citation
Administered circulating microparticles derived from lung cancer patients markedly improved angiogenesis, blood flow and ischemic recovery in rat critical limb ischemia. 2015, 13:59 J Transl Med
Note
This article is freely available via Open Access. Click on the 'Additional Link' above to access the full-text via the publisher's site.